As significant evidence of permafrost degradation,thermokarst lakes play an important role in the permafrost regions by regulating hydrology,ecology,and biogeochemistry.In the Sources Area of the Yellow River(SAYR),pe...As significant evidence of permafrost degradation,thermokarst lakes play an important role in the permafrost regions by regulating hydrology,ecology,and biogeochemistry.In the Sources Area of the Yellow River(SAYR),permafrost degradation has accelerated since the 1980s,and numerous thermokarst lakes have been discovered.In this paper,we use Sentinel-2 images to extract thermokarst lake boundaries and perform a regional-scale study on their geometry across the permafrost region in the SAYR.We also explored the spatiotemporal variations and potential drivers from the perspectives of the permafrost,climate,terrain and vegetation conditions.The results showed that there were 47,518 thermokarst lakes in 2021 with a total area of 190.22×106 m^(2),with an average size of 4,003.3 m^(2).The 44,928 ponds(≤10,000 m^(2))predominated the whole lake number(94.1%)but contributed to a small portion of the total lake area(28.8%).With 2,590 features(5.9%),small-sized(10,000 to 100,000 m^(2))and large-sized lakes(>100,000 m^(2))constituted up to 71.2%of the total lake area.Thermokarst lakes developed more significantly in warm permafrost regions than in cold permafrost areas;74.1%of lakes with a total area of 119.6×106 m^(2)(62.9%),were distributed in warm permafrost regions.Most thermokarst lakes were likely to develop within the elevation range of 4,500~4,800 m,on flat terrain(slope<10°),on SE and S aspects and in alpine meadow areas.The thermokarst lakes in the study region experienced significant shrinkage between 1990 and 2021,characterized by obvious lake drainage;the lake numbers decreased by 5418(56.1%),with a decreasing area of 58.63×106 m^(2)(49.0%).This shrinkage of the thermokarst lake area was attributable mainly to the intensified degradation of rich-ice permafrost thawing arising from continued climate warming,despite the wetting climatic trend.展开更多
The pharmacokinetics of milbemycin oxime was investigated in dogs following oral(per os, PO) and intravenous(IV) administration. Three groups of dogs received milbemycin oxime tablets as a single PO dose equal to 0.25...The pharmacokinetics of milbemycin oxime was investigated in dogs following oral(per os, PO) and intravenous(IV) administration. Three groups of dogs received milbemycin oxime tablets as a single PO dose equal to 0.25, 0.5 and 1.0 mg · kg-1 of milbemycin oxime, respectively, another group received a single IV dose of 0.5 mg · kg-1. Blood samples were collected at predetermined times after drug administration and the milbemycin oxime concentrations in plasma were determined by LC-MS/MS. The drug protein binding in dog plasma in vitro was determined by equilibrium dialysis at concentrations spanning the range of values observed in vivo in dog plasma. After PO administration at doses of 0.25, 0.5 and 1.0 mg · kg-1, milbemycin oxime was slowly absorbed and eliminated, the time to reach the maximum plasma concentration(Tmax) was 4.14±0.20, 4.27±0.14 and 4.06±0.13 h, the mean absorption time(MAT) was 19.06, 13.67 and 11.77 h, the terminal rate half-life(t1/2λz) was 15.06±0.37, 11.09±0.54 and 9.76±0.89 h and the total body clearance(Cl) was 1.15±0.05, 1.18±0.03 and 1.17±0.07 m L · min-1 · kg-1, respectively. The maximum plasma concentration(Cmax, 36.50±1.40, 76.11±2.77 and 182.05±7.20 ng · m L-1, respectively) and the area under the first-moment curve(AUC-10→∞, 985.83±49.46, 1 663.12±51.42 and 3 558.04±197.88 mg · h · L, respectively) increased accordingly to the administered dose rates; the oral bioavailabilities were estimated to be 88.61%, 74.75% and 79.96%, respectively. The values of fu were 0.12%, 0.14% and 0.13% in dog plasma, respectively. In conclusion, the pharmacokinetics of milbemycin oxime in dogs following oral administration revealed its higher oral bioavailability and advantageous pharmacokinetic properties, such as its lower total body clearance and longer elimination half-life, and indicated that the single oral dose of 0.50 mg · kg-1 of milbemycin oxime which was recommended in all the parasitological efficacy studies allowed an adequate concentration of the drug.展开更多
基金supported by the Natural Science Foundation of Qinghai Province,China(No.2021-ZJ940Q)the Open Project of State Key Laboratory of Plateau Ecology and Agriculture,Qinghai University(No.2022-ZZ-02)。
文摘As significant evidence of permafrost degradation,thermokarst lakes play an important role in the permafrost regions by regulating hydrology,ecology,and biogeochemistry.In the Sources Area of the Yellow River(SAYR),permafrost degradation has accelerated since the 1980s,and numerous thermokarst lakes have been discovered.In this paper,we use Sentinel-2 images to extract thermokarst lake boundaries and perform a regional-scale study on their geometry across the permafrost region in the SAYR.We also explored the spatiotemporal variations and potential drivers from the perspectives of the permafrost,climate,terrain and vegetation conditions.The results showed that there were 47,518 thermokarst lakes in 2021 with a total area of 190.22×106 m^(2),with an average size of 4,003.3 m^(2).The 44,928 ponds(≤10,000 m^(2))predominated the whole lake number(94.1%)but contributed to a small portion of the total lake area(28.8%).With 2,590 features(5.9%),small-sized(10,000 to 100,000 m^(2))and large-sized lakes(>100,000 m^(2))constituted up to 71.2%of the total lake area.Thermokarst lakes developed more significantly in warm permafrost regions than in cold permafrost areas;74.1%of lakes with a total area of 119.6×106 m^(2)(62.9%),were distributed in warm permafrost regions.Most thermokarst lakes were likely to develop within the elevation range of 4,500~4,800 m,on flat terrain(slope<10°),on SE and S aspects and in alpine meadow areas.The thermokarst lakes in the study region experienced significant shrinkage between 1990 and 2021,characterized by obvious lake drainage;the lake numbers decreased by 5418(56.1%),with a decreasing area of 58.63×106 m^(2)(49.0%).This shrinkage of the thermokarst lake area was attributable mainly to the intensified degradation of rich-ice permafrost thawing arising from continued climate warming,despite the wetting climatic trend.
基金Supported by Natural Science Fund of Heilongjiang Province(C201424)
文摘The pharmacokinetics of milbemycin oxime was investigated in dogs following oral(per os, PO) and intravenous(IV) administration. Three groups of dogs received milbemycin oxime tablets as a single PO dose equal to 0.25, 0.5 and 1.0 mg · kg-1 of milbemycin oxime, respectively, another group received a single IV dose of 0.5 mg · kg-1. Blood samples were collected at predetermined times after drug administration and the milbemycin oxime concentrations in plasma were determined by LC-MS/MS. The drug protein binding in dog plasma in vitro was determined by equilibrium dialysis at concentrations spanning the range of values observed in vivo in dog plasma. After PO administration at doses of 0.25, 0.5 and 1.0 mg · kg-1, milbemycin oxime was slowly absorbed and eliminated, the time to reach the maximum plasma concentration(Tmax) was 4.14±0.20, 4.27±0.14 and 4.06±0.13 h, the mean absorption time(MAT) was 19.06, 13.67 and 11.77 h, the terminal rate half-life(t1/2λz) was 15.06±0.37, 11.09±0.54 and 9.76±0.89 h and the total body clearance(Cl) was 1.15±0.05, 1.18±0.03 and 1.17±0.07 m L · min-1 · kg-1, respectively. The maximum plasma concentration(Cmax, 36.50±1.40, 76.11±2.77 and 182.05±7.20 ng · m L-1, respectively) and the area under the first-moment curve(AUC-10→∞, 985.83±49.46, 1 663.12±51.42 and 3 558.04±197.88 mg · h · L, respectively) increased accordingly to the administered dose rates; the oral bioavailabilities were estimated to be 88.61%, 74.75% and 79.96%, respectively. The values of fu were 0.12%, 0.14% and 0.13% in dog plasma, respectively. In conclusion, the pharmacokinetics of milbemycin oxime in dogs following oral administration revealed its higher oral bioavailability and advantageous pharmacokinetic properties, such as its lower total body clearance and longer elimination half-life, and indicated that the single oral dose of 0.50 mg · kg-1 of milbemycin oxime which was recommended in all the parasitological efficacy studies allowed an adequate concentration of the drug.
